The day we visited Johns Hopkins's Laura Guay (left) and Makerere University's Philippa Musoke at their new lab building on Old Mulago Hill in Kampala, Uganda, happened to be the very day that the country's first shipment of nevirapine had arrived. Until then, the only nevirapine Ugandans had access to had come from a trial that Guay and Musoke helped run, which 8 months earlier proved that the drug could dramatically cut transmission rates of HIV from mother to baby. "With nevirapine, I'm really excited," said Musoke. "It's really a project that's doable in developing countries. We do a lot of research that's interesting but, logistically, it's not possible."

(Photograph by Malcolm Linton)

To Advertise   |   Find Products